Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Jazz Pharmaceuticals plc

NASDAQ: JAZZ · Life Sciences · 12 alerts · CIK 1232524

Share price
$239.77Close, Nov 16
Market cap
$15.4B
Shares outstanding
64.19MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Jazz Pharmaceuticals plc filings on SEC EDGAR ↗

4:03 PM ET 8-K
Business Update

Jazz Pharmaceuticals Business Update

Jazz Pharmaceuticals provided a preliminary update on its Q3 2026 financial results, estimating a $755 million pre-tax charge for acquired in-process research and development (IPR&D) related to its acquisition of Actio Biosciences. This non-deductible charge is expected to have an unfavorable impact of approximately $11.00 on both GAAP and non-GAAP adjusted earnings per share for the quarter.

Counterparty
Actio Biosciences, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.